The global virtual biopsy market, valued at USD 0.78 billion in 2025, is projected to reach USD 0.85 billion in 2026 and USD 3.02 billion by 2035, representing a CAGR of 15% during the forecast period 2026 to 2035. Currently, the magnetic resonance imaging segment holds the majority share (>30%) in the overall market.

The global smart labels market, valued at USD 5.4 billion in 2025, is projected to reach USD 6.4 billion in 2026 and USD 24.0 billion by 2035, with a 16% CAGR during the forecast period 2026 to 2035. In terms of type of technology, the RFID segment holds the highest share (75%) of the market. With regards to type of packaging, the primary packaging segment dominates the global market with 95% market share. Based on the type of primary packaging, the syringes reagents hold the largest market shar...

The dermal fillers market valued at USD 3.33 billion in 2024, is project to reach USD 3.64 billion in 2025 and USD 8.81 billion by 2035, representing a higher CAGR of 9.25% during the forecast period 2025 to 2035. Amongst the end users, the hospitals segment dominates the global market.  Based on the distribution channel, direct distribution channel segment holds the largest market share (nearly 80%. In terms of geography, North America captures majority of the market share (close to 50%).

The metaverse in healthcare market, valued at $9.6 billion in 2024, is projected to reach $14.6 billion in 2025 and $219.1 billion by 2035, representing a CAGR of 31.1% during the forecast period. Overall, metaverse and healthcare industry has the potential to streamline healthcare delivery, reduce treatment costs, and improve patient outcomes by facilitating more personalized healthcare experiences.

The global medical robotics market, valued at USD 11.2 billion in 2025, is projected to reach USD 12.3 billion in 2026 and USD 31.3 billion by 2035, with a 4.5% CAGR during the forecast period 2026 to 2035. In terms of type of medical robot, the surgical robots segment holds the highest share (50%) of the market. Based on the deployment model, the on-premises hold the largest market share (nearly 90%). North America captures the majority of the market share, and Asia-Pacific is likely to grow...

The global digital pathology market, valued at USD 1.01 billion in 2025, is projected to reach USD 1.09 billion in 2026 and USD 2.32 billion by 2035, with a 8.74% CAGR during the forecast period 2026 to 2035. The digital pathology market analysis also features the likely distribution of the current and forecasted opportunity within the digital pathology domain across various segments, such as type of neural network, type of assay, type of end-user, area of application, target disease indicati...

The cell line development market size valued at USD 1.46 billion in 2025, is project to reach USD 1.69 billion in 2026 and USD 4.50 billion by 2035, representing a higher CAGR of 11.5% during the forecast period 2026 to 2035. In terms of source of cell line, mammalian cells segment dominates the market with a 74% revenue share due to their critical role in producing complex proteins, monoclonal antibodies, and cell- and gene-based therapies. Notably, mid-sized players lead the market with a 39%...

The global agricultural biologicals market, valued at USD 3,571 million in 2025, is projected to reach USD 3,882 million in 2026 and USD 7,011 million by 2035, with a 6.8% CAGR during the forecast period 2026 to 2035. In terms of type of device, the neurothrombectomy device segment holds the highest share (~50%) of the market. With regards to therapeutic application, the ischemic stroke segment dominates the global market with more than 45% market share. North America captures the majority of...

The single use bioreactors market, valued at USD 4.32 billion in 2025, is projected to reach USD 4.81 billion in 2026 and USD 10.48 billion by 2035, with a CAGR of 9.03% during the forecast period, 2026 to 2035. The ongoing technological advancements focused on the development of improved versions of biosensors and single use bioreactor bags are likely to encourage the biopharmaceutical companies to adopt disposable bioreactors for continuous bioprocessing, representing a lucrative opportunity f...

Owing to the rising space exploration, and requirement of medicine, space medicine demand is likely to increase in the upcoming years. The emerging needs has catered the attention of pharmaceutical industries to undertake several initiatives to strengthen the development of space medicine. However, the primary focus will be on telemedicine, remote monitoring / surgery technologies, and virtual consultation to provide quick support to astronauts to improve overall well-being.Additionally, several...

The global virtual clinical trials market, valued at $12.9 billion in 2025, is projected to reach $13.6 billion in 2026 and $30.5 billion by 2035, representing a CAGR of 9.4% during the forecast period 2026 to 2035. In terms of type of study, the interventional segment holds the highest share (75%) of the market. With regards to mode of virtual clinical trials, the hybrid clinical trials segment dominates the global market. Based on the therapeutic area, the oncological disorders segment holds t...

The global taste masking services market, valued at USD 260 million in 2025, is projected to reach USD 276 million in 2026 and USD 476 million by 2035, with a 6.3% CAGR during the forecast period 2026 to 2035. Even though the demand for biologics is increasing rapidly, the oral solid dosage captures the largest share in the pharmaceutical industry, estimated to reach more than USD 900 billion by 2027. However, one of the major concerns is that orally administered dosage forms have active pharmac...

With increasing demand, several market players, such as Medtronic (US), and Abbott Laboratories (US) are undertaking initiatives to develop minimally invasive surgery solutions. For instance, in October 2025, Medtronic announced the initiation of the embrace gynecology investigational device exemption (IDE) US clinical study to evaluate the effectiveness and safety of its Hugo™ robotic-assisted surgery (RAS) system in robotic-assisted gynecological procedures. As more market players focus on t...

Medical waste management market size valued at USD 5.1 billion in 2024, is project to reach USD 5.5 billion in 2025 and USD 19.4 billion by 2035, at CAGR of 13.4% during the forecast period. 2025 to 2035. In terms of service offered, the treatment segment holds the highest share (50%) of the market. With regards to type of waste, the hazardous waste segment dominates the global market with 90% market share. Based on the treatment site, the offsite segment holds the largest market share (nearly 6...

The lab automation market, valued at USD 6.5 billion in 2025, is projected to reach USD 7.1 billion in 2026 and USD 16.1 billion by 2035, with a 9.5% CAGR during the forecast period 2026 to 2035. According to a research article published by Nature, over 70% of scientists were unable to replicate a previously published experiment. As a result, lab automation has emerged as the most suitable alternative since it has the ability to overcome the issues associated with manual handling. Also, automat...

The global cannabis testing market, valued at USD 2.6 billion in 2025, is projected to reach USD 3.1 billion in 2026 and USD 20.2 billion by 2035, with a 23% CAGR during the forecast period 2026 to 2035. Studies have shown that cannabis can provide substantial relief from adverse effects, such as chemotherapy-induced nausea and chronic pain associated with multiple sclerosis. In fact, three cannabis-derived prescription medications have already been approved for sale across the US. Further, ther...

The global nutrigenomics market, valued at USD 0.92 billion in 2025, is projected to reach USD 1.04 billion in 2026 and USD 3.07 billion by 2035, with a 12.8% CAGR during the forecast period 2026 to 2035. It is estimated that there are around 20,000 genes present in the human body, all of which interact with the nutrients in the food, either directly or indirectly. Nutrigenomics typically refers to the study of the relationship between nutrition, human genomes, and health. Presently, more than...

The global metabolomics market, valued at USD 265 million in 2025, is projected to reach USD 305 million in 2026 and USD 1,059 million by 2035, with a 14.8% CAGR during the forecast period 2026 to 2035. With the growing prominence of personalized medicine, there is an increased demand for rapid, highly sensitive and accurate quantification methods, such as metabolomics, to analyze clinical specimens. In fact, 50% of the total drug candidates are reported to emanate from pre-existing metabolites....

The companion diagnostics (CDx) development market, valued at USD 892 million in 2025, is projected to reach USD 779 million in 2026 and USD 1,796 million by 2035, with a 9.7% CAGR during the forecast period 2026 to 2035. The introduction of companion diagnostics has revolutionized healthcare practices and led to a paradigm shift from the conventional, one-drug-for-all treatment to patient-centric personalized treatment. Till date, close to 170 companion diagnostics have been approved by the USF...

The abuse deterrent formulations market, valued at USD 39.8 billion in 2025, is projected to reach USD 42.5 billion in 2026 and USD 54.8 billion by 2030, with a 6.6% CAGR during the forecast period 2026 to 2030. Although the healthcare industry relies on patient to take medications responsibly, in 2017, close to 18 million individuals were reported to have misused prescription drugs, in the US. Moreover, the same study reported 1.5 million people abusing tranquilizers, over 1 million abusing pr...